Corcept Therapeutics Incorporated
IT ˙ BIT ˙ US2183521028
62,12 € ↑0,86 (1,40%)
2026-06-03
AKTIENPREIS
SecurityIT:1CORT / Corcept Therapeutics Incorporated
InstitutionUBS Group AG
Latest Disclosed Ownership1,363,668 shares
Latest Disclosed Value $ 54,969,457
UBS Group AG ownership in 1CORT / Corcept Therapeutics Incorporated

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,363,668 shares of Corcept Therapeutics Incorporated (IT:1CORT) valued at $46,146,525 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 414,851 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 228.71% during the quarter. The current value of the position is $84,711,056 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (1CORT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1CORT / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,363,668 948,817 228.71 54,969 280.78 0.0015
2026-01-29 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 414,851 -135,087 -24.56 14,437 -68.41 0.0023
2025-11-13 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 549,938 442,898 413.77 45,705 481.78 0.0072
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 107,040 -265,613 -71.28 7,857 -81.54 0.0014
2025-05-13 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 372,653 122,491 48.96 42,564 237.68 0.0078
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 250,162 71,966 40.39 12,606 52.86 0.0023
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 178,196 11,819 7.10 8,247 52.56 0.0018
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 166,377 -2,957 -1.75 5,406 26.73 0.0013
2024-05-13 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 169,334 36,300 27.29 4,266 -1.27 0.0011
2024-02-09 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 133,034 64,483 94.07 4,321 131.39 0.0013
2023-11-09 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 68,551 20,627 43.04 1,868 75.14 0.0006
2023-08-11 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 47,924 13,493 39.19 1,066 43.09 0.0004
2023-05-12 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 34,431 3,106 9.92 746 17.14 0.0003
2023-02-08 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 31,325 -1,826 -5.51 636 -25.18 0.0002
2022-11-10 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 33,151 995 3.09 850 11.26 0.0004
2022-08-10 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 32,156 -210,835 -86.77 764 -86.04 0.0003
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 242,991 3,415 1.43 5,472 15.35 0.0018
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 239,576 201,964 536.97 4,744 540.22 0.0014
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 37,612 -63,820 -62.92 741 -66.80 0.0002
2021-08-13 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 101,432 59,863 144.01 2,232 125.68 0.0007
2021-05-12 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 41,569 621 1.52 989 -7.74 0.0003
2021-02-11 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 40,948 -1,052 -2.50 1,072 46.65 0.0004
2020-11-12 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 42,000 -90,304 -68.25 731 -67.15 0.0003
2020-07-31 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 132,304 -185,279 -58.34 2,225 -41.08 0.0009
2020-05-01 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 317,583 57,166 21.95 3,776 19.83 0.0018
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 260,417 106,234 68.90 3,151 44.61 0.0011
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 154,183 3,074 2.03 2,179 29.32 0.0008
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 151,109 82,891 121.51 1,685 110.36 0.0006
2019-05-14 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 68,218 -38,194 -35.89 801 -43.67 0.0003
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 106,412 46,847 78.65 1,422 70.30 0.0006
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 59,565 -36,237 -37.82 835 -44.56 0.0003
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 95,802 40,715 73.91 1,506 66.23 0.0007
2018-05-15 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 55,087 -3,501 -5.98 906 -14.37 0.0004
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 58,588 -17,639 -23.14 1,058 -28.08 0.0004
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 76,227 10,153 15.37 1,471 88.83 0.0007
2017-11-14 2017-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 66,074 -2,696 -3.92 779 3.32 0.0004
2017-08-14 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 66,074 -2,696 779
2017-11-14 2017-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 68,770 -13,397 -16.30 754 26.51 0.0004
2017-05-12 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 68,770 -13,397 754
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 82,167 10,849 15.21 596 28.45 0.0003
2016-11-14 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 71,318 -86,010 -54.67 464 -45.98 0.0003
2016-08-12 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 157,328 44,940 39.99 859 63.31 0.0005
2016-05-12 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 112,388 -23,612 -17.36 526 -22.30 0.0004
2016-02-16 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 136,000 23,888 21.31 677 60.81 0.0004
2015-11-13 2015-09-30 13F CORCEPT THERAPEUTICS COM 218352102 112,112 1,168 1.05 421 -36.88 0.0003
2015-08-14 2015-06-30 13F CORCEPT THERAPEUTICS COM 218352102 110,944 -11,805 -9.62 667 -3.05 0.0004
2015-05-14 2015-03-31 13F CORCEPT THERAPEUTICS COM 218352102 122,749 -11,829 -8.79 688 70.72 0.0005
2015-02-17 2014-12-31 13F CORCEPT THERAPEUTICS COM 218352102 134,578 134,578 403 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F CORCEPT THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2026-01-29 2025-12-31 13F CORCEPT THERAPEUTICS COM Call 9,400 327 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 n/a n/a n/a
2026-01-29 2025-12-31 13F CORCEPT THERAPEUTICS COM Put 2,038,600 70,943 n/a n/a n/a
2020-05-01 2020-03-31 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM Put 69,800 845 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.